Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.53

+4.5%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2809)	3/3/2001 5:00:16 PM
From: Oak Tree	Read Replies (3) of 52153

Just a heads up. The sales reps at NOVT seem mighty happy. They are paid heavily in stock, though they probably don't really know any results. Specifically, the results of the non-stent trial will be coming out soon. If they outperform stents, many places could start using radiation instead of stents. This would be good for NOVT over the short run though they would have competition around the corner with the afterloading systems. The stock made a substantial jump on Friday. I wonder if info is on the street. I missed getting any shares. I think I'll hope for a pullback Monday and get back in.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next